ALNYLAM PHARMACEUTICALS, INC. 8-K

Company

ALNYLAM PHARMACEUTICALS, INC.

Filed

February 15, 2024

Period of Report

February 15, 2024

Accession Number

0001157523-24-000253

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →